BioSpace News Archive

he 2018 BIO International Convention, the world’s premier life sciences event, today kicked off four days of inspiring keynote speeches, fireside chats and educational programming to celebrate 25 years of biotechnology innovation and cutting-edge advancements under the theme “Make History.”

IPI-549 Well Tolerated in Combination Dose Escalation with Nivolumab

CytoSorbents is a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world

Cost Analysis Data indicates Pure-Vu® System has the potential to reduce inadequate colon prep rate for colonoscopy, leading to lower costs and lower projected incidence of CRC in average and high-risk patients

INNOVATE-3 will test the efficacy of Tumor Treating Fields combined with paclitaxel in patients with recurrent, platinum-resistant ovarian cancer

Merck announced interim data from a cohort of the Phase 2 KEYNOTE-158 study evaluating KEYTRUDA.

Tartu University Hospital has joined the TriNetX global health research network, in an effort to grow its clinical trial participation internationally.

Egalet Corporation announced Bob Radie, president and chief executive officer, will present in panels at two upcoming conferences in June.

Soligenix, Inc. announced that Dr. Oreola Donini, Chief Scientific Officer, will be presenting preclinical and clinical data illustrating the potential utility of the Innate Defense Regulator technology in the treatment of infectious disease at the upcoming American Society of Microbiology Microbe Conference.

Innovus Pharmaceuticals, Inc. announced the approval by Health Canada of its product ProstaGorx™ as a Natural Health Product (NPN #80085717) for the relief of urologic symptoms.